HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guy E H M Rutten Selected Research

Glucose (Dextrose)

1/2020Population-based screen-detected type 2 diabetes mellitus is associated with less need for insulin therapy after 10 years.
1/2016Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes.
11/2013Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
10/2012Diabetes: glycaemic control in type 2 (drug treatments).
3/2012Diabetes, hyperglycaemia, and acute ischaemic stroke.
9/2011Lower postprandial glucose responses at baseline and after 4 weeks use of a diabetes-specific formula in diabetes type 2 patients.
5/2009Insulin therapy in type 2 diabetes: what is the evidence?
12/2008Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study.
2/2008Perceived diabetes status is independently associated with glucose monitoring behaviour among type 2 diabetes mellitus patients.
6/2007Screen detected subjects with type 2 diabetes and impaired glucose tolerance have more adverse cardiovascular risk than subjects with impaired fasting glucose especially when they are obese: the ADDITION Netherlands study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guy E H M Rutten Research Topics

Disease

33Type 2 Diabetes Mellitus (MODY)
01/2022 - 03/2002
6Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 04/2010
6Glucose Intolerance
11/2013 - 06/2007
4Heart Failure
03/2013 - 08/2008
3Body Weight (Weight, Body)
02/2015 - 09/2011
3Myocardial Infarction
12/2014 - 04/2010
3Stroke (Strokes)
03/2012 - 04/2010
2Cognitive Dysfunction
01/2019 - 04/2015
2Insulin Resistance
01/2016 - 09/2011
2Unstable Angina
04/2010 - 04/2010
2Pneumonia (Pneumonitis)
08/2008 - 09/2007
1Hyperglycemia
01/2020
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2018
1Diabetes Complications
01/2017
1Inflammation (Inflammations)
10/2015
1Vitamin B 12 Deficiency (Vitamin B12 Deficiency)
02/2015
1Peripheral Nervous System Diseases (PNS Diseases)
07/2014
1Atrial Fibrillation
11/2013
1Hypertension (High Blood Pressure)
11/2013
1Coronary Disease (Coronary Heart Disease)
08/2013
1Diabetes Mellitus
10/2012
1Ischemic Stroke
03/2012
1Infections
04/2011
1Urinary Tract Infections (Urinary Tract Infection)
08/2010
1Hypoglycemia (Reactive Hypoglycemia)
04/2010
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2010
1Systolic Heart Failure
12/2009
1Weight Gain
05/2009
1Chronic Obstructive Pulmonary Disease (COPD)
08/2008
1Human Influenza (Influenza)
08/2006
1Fatigue
04/2005
1Obesity
03/2002
1Diabetic Foot
03/2002

Drug/Important Bio-Agent (IBA)

13Insulin (Novolin)FDA Link
01/2020 - 03/2002
10Glucose (Dextrose)FDA LinkGeneric
01/2020 - 06/2007
7CholesterolIBA
10/2015 - 04/2010
4Metformin (Glucophage)FDA LinkGeneric
01/2016 - 05/2009
4Nateglinide (Starlix)FDA LinkGeneric
11/2013 - 04/2010
4Valsartan (Vals)FDA Link
11/2013 - 04/2010
3Anti-Bacterial Agents (Antibiotics)IBA
04/2011 - 08/2008
2SDMIBA
01/2022 - 02/2015
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 12/2014
2Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
04/2015 - 02/2015
2LipidsIBA
02/2015 - 09/2011
1A-factor (Streptomyces)IBA
01/2019
1Hemoglobins (Hemoglobin)IBA
10/2017
1Hypoglycemic Agents (Hypoglycemics)IBA
10/2017
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2016
1LDL CholesterolIBA
01/2016
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1AdiponectinIBA
10/2015
1C-Reactive ProteinIBA
10/2015
1Retinaldehyde (Retinal)IBA
07/2014
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
08/2013
1Antihypertensive Agents (Antihypertensives)IBA
08/2013
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
08/2013
1AlbuminsIBA
03/2013
1CreatinineIBA
03/2013
1Blood Glucose (Blood Sugar)IBA
10/2012
1FructosamineIBA
09/2011
1Short-Acting InsulinIBA
04/2010
1SecretagoguesIBA
04/2010
1Adenosine Triphosphate (ATP)IBA
01/2010
1pro-brain natriuretic peptide (1-76)IBA
12/2009
1Long-Acting Insulin (Insulin, Long Acting)FDA Link
05/2009
1Prednisone (Sone)FDA LinkGeneric
08/2008
1cyclo(Arg-Pro) (CI 4)IBA
09/2007
1Influenza Vaccines (Influenza Vaccine)FDA Link
08/2006
1mesoglycanIBA
08/2006
1VaccinesIBA
08/2006
1Dietary Fats (Dietary Fat)IBA
03/2004
1Tolbutamide (Orinase)FDA LinkGeneric
01/2004
1AcarboseFDA LinkGeneric
01/2004
1Indicators and Reagents (Reagents)IBA
04/2003

Therapy/Procedure

11Therapeutics
01/2021 - 03/2002
3Glycemic Control
01/2020 - 08/2015
2Polypharmacy
07/2013 - 11/2009
1Secondary Prevention
12/2014
1Aftercare (After-Treatment)
10/2014
1Home Nursing (Nursing, Home)
03/2002
1Surgical Amputation (Amputations)
03/2002